MedTrace Logo

BIIB033 Single Ascending Dose Study in Healthy Volunteer Subjects

NCT01052506 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-01-09

No results posted yet for this study

Summary

The primary objective of the study is to evaluate the safety and tolerability of single dose of BIIB033 administered to healthy adult volunteers.

Conditions

  • Healthy

Interventions

DRUG

BIIB033

Single, escalating doses of BIIB033 (8 cohorts IV, 1 cohort SC)

DRUG

Placebo

Single dose of placebo comparator (8 cohorts IV, 1 cohort SC)

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States
  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01052506 on ClinicalTrials.gov